Repatha Can Drop Your Cholesterol to 30, But Here’s the Truth No One Likes to Talk About
If you’ve been told you have high cholesterol, chances are you’ve heard about Repatha.
Patients ask me about it all the time.
Colleagues talk about it.
And honestly, it sounds like a miracle drug.
An injection every two weeks that can drop your LDL, the “bad cholesterol,” into the 20s or 30s. Numbers most people could never reach with diet or statins alone.
So naturally, the question becomes:
If my cholesterol gets that low, doesn’t that mean I’ll live longer?
The answer is more nuanced than most people expect, and that’s what I want to talk through with you today.
What Repatha Actually Does (in Plain English)
Repatha, also called evolocumab, is what’s known as a PCSK9 inhibitor. That sounds complicated, but the idea is simple.
Your liver is constantly pulling LDL cholesterol out of your blood.
PCSK9 is a protein that destroys the receptors your liver uses to do that.
Repatha blocks PCSK9, which allows your liver to act like a much more powerful vacuum, pulling LDL out of circulation.
The result?
LDL levels can drop 50 to 60 percent, often within weeks.
That part is real. The drug works extremely well at lowering cholesterol.
The Trial Results Everyone Should Understand
The most important studies on Repatha were done in very high-risk patients. These were people who had already had:
A heart attack
A stroke
Known artery disease
In these patients, Repatha reduced heart attacks, reduced strokes, and reduced the need for stents and procedures.
Those are meaningful outcomes. Fewer heart attacks and strokes matter.
But here is the part that surprises many people.
👉 Repatha did not extend lifespan in these trials.
People lived better, with fewer events, but they did not live longer.
That does not mean the drug is useless. It means we need to be honest about what problem it actually solves.
Relative Risk vs Absolute Risk (This Part Is Critical)
You will often hear headlines like:
“Heart attacks reduced by 27%!”
That is relative risk — and it sounds huge.
But the absolute risk reduction was closer to 1 to 2 percent.
That still translates to thousands of prevented events across a population, which is important. But it also means the benefit looks very different depending on who you are.
If you are high risk, that reduction may matter a lot.
If you are lower risk, the benefit may be small.
This is why one-size-fits-all cholesterol treatment does not work.
What About Side Effects?
This is one of the reassuring parts.
Unlike statins, Repatha does not:
Increase diabetes risk
Cause muscle injury
Raise liver enzymes
The most common side effect is a mild injection-site reaction.
Despite early fears, studies looking closely at cognition found no evidence of memory loss or brain fog, even when LDL dropped into the 20s.
From a safety standpoint, the data so far has been reassuring, though it is still newer than statins and we do not yet have decades of long-term data.
So Who Is Repatha Really For?
In general, Repatha makes the most sense for people who are:
Very high risk
Have already had a heart attack or stroke
Have known cardiovascular disease
Have very high Lp(a) with a strong family history
Truly cannot tolerate statins
For most people, it is not a first-line drug.
Guidelines usually recommend:
Statins first
Then ezetimibe (Zetia)
Only then considering Repatha if LDL remains high
It is also expensive, requires insurance approval, and is a long-term commitment.
The Question That Matters Most
Here is what I want you to take away, whether you are thinking about Repatha or any medical treatment.
Statistics describe groups — but you are one person.
Your risk factors, values, tolerance for medication, financial situation, and goals all matter.
Some people want to reduce every possible future event.
Others want simplicity and fewer medications.
Neither approach is wrong. But the decision should be informed, not driven by hype or fear.
Thank you for reading. If this was helpful, consider sharing it with someone who is worried about cholesterol.
-Dr. Haque
Watch the full video here👇


